Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Other Non-Current Assets (2016 - 2025)

CorMedix's Other Non-Current Assets history spans 13 years, with the latest figure at $642066.0 for Q2 2025.

  • For Q2 2025, Other Non-Current Assets rose 514.85% year-over-year to $642066.0; the TTM value through Jun 2025 reached $642066.0, up 514.85%, while the annual FY2024 figure was $105368.0, N/A changed from the prior year.
  • Other Non-Current Assets for Q2 2025 was $642066.0 at CorMedix, roughly flat from $642066.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $642066.0 in Q1 2025 and bottomed at $102295.0 in Q1 2021.
  • The 5-year median for Other Non-Current Assets is $105084.0 (2024), against an average of $173891.2.
  • The largest annual shift saw Other Non-Current Assets tumbled 40.39% in 2021 before it skyrocketed 518.33% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $132000.0 in 2021, then fell by 22.48% to $102320.0 in 2022, then grew by 0.34% to $102664.0 in 2023, then increased by 2.63% to $105368.0 in 2024, then skyrocketed by 509.36% to $642066.0 in 2025.
  • Per Business Quant, the three most recent readings for CRMD's Other Non-Current Assets are $642066.0 (Q2 2025), $642066.0 (Q1 2025), and $105368.0 (Q4 2024).